Purpose: Detailed data on the mortality of epilepsy are still lacking from resource-poor settings. We conducted a long-term follow-up survey in a cohort of people with convulsive epilepsy in rural areas of China. In this longitudinal prospective study we investigated the causes of death and premature mortality risk among people with epilepsy. Methods: We attempted to trace all 2,455 people who had previously participated in a pragmatic assessment of epilepsy management at the primary health level. Putative causes of death were recorded for those who died, according to the International Classification of Diseases. We estimated proportional mortality ratios (PMRs) for each cause, and standardized mortality ratios (SMRs) for each age-group and cause. Survival analysis was used to detect risk factors associated with increased mortality. Key Findings: During 6.1years of follow-up there were 206 reported deaths among the 1,986 people with epilepsy who were located. The highest PMRs were for cerebrovascular disease (15%), drowning (14%), self-inflicted injury (13%), and status epilepticus (6%), with probable sudden unexpected death in epilepsy (SUDEP) in 1%. The risk of premature death was 2.9 times greater in people with epilepsy than in the general population. A much higher risk (SMRs 2837) was found in young people. Duration of epilepsy and living in a waterside area were independent predictors for drowning. Significance: Drowning and status epilepticus were important, possibly preventable, causes of death. Predictors of increasing mortality suggest interventions with efficient treatment and education to prevent premature mortality among people with epilepsy in resource-poor settings.
基金:
Chinese Ministry of Health; Stichting Epilepsie Instellingen Nederland; Department of Health's National Institute for Health Research Biomedical Research CentresNational Institute for Health Research (NIHR); Dr Marvin Weil Epilepsy Research Fund; China Association Against Epilepsy; EisaiEisai Inc; Johnson JohnsonJohnson & Johnson USA; PfizerPfizer; UCB PharmaUCB Pharma SA; UCBUCB Pharma SA; JanssenJohnson & Johnson USAJanssen Biotech Inc; GSKGlaxoSmithKline; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; European UnionEuropean Union (EU); Wellcome TrustWellcome Trust; World Health Organization (WHO)World Health Organization; National Epilepsy Funds of the Netherlands; Epilepsy Society
第一作者机构:[1]Fudan Univ, Huashan Hosp, WHO Collaborating Ctr Res & Training Neurosci, Inst Neurol, Shanghai 200040, Peoples R China;
通讯作者:
通讯机构:[1]Fudan Univ, Huashan Hosp, WHO Collaborating Ctr Res & Training Neurosci, Inst Neurol, Shanghai 200040, Peoples R China;[16]Fudan Univ, Huashan Hosp, Inst Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China
推荐引用方式(GB/T 7714):
Ding Ding,Wang Wenzhi,Wu Jianzhong,et al.Premature mortality risk in people with convulsive epilepsy: Long follow-up of a cohort in rural China[J].EPILEPSIA.2013,54(3):512-517.doi:10.1111/epi.12048.
APA:
Ding, Ding,Wang, Wenzhi,Wu, Jianzhong,Yang, Hongchao,Li, Shichuo...&Sander, Josemir W..(2013).Premature mortality risk in people with convulsive epilepsy: Long follow-up of a cohort in rural China.EPILEPSIA,54,(3)
MLA:
Ding, Ding,et al."Premature mortality risk in people with convulsive epilepsy: Long follow-up of a cohort in rural China".EPILEPSIA 54..3(2013):512-517